Torrent Pharma Recalls Robafen DM Syrup Due to Bacterial Contamination Risk
Torrent Pharma is recalling Robafen DM Syrup due to potential contamination with Burkholderia cepacia and Ralstonia pickettii.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe rating under the rubric, particularly given the potential for contamination with specific bacterial pathogens.
Plain-English summary
Torrent Pharma Inc is recalling Robafen DM Syrup, a cough and cold medication containing dextromethorphan and guaifenesin. The recall is being conducted due to current Good Manufacturing Practice (cGMP) deviations that created a potential for product contamination with Burkholderia cepacia and Ralstonia pickettii.
The affected product is distributed by Major Pharmaceuticals Inc. and is available in 4 oz, 8 oz, and 16 oz bottles. Approximately 1,500,672 bottles were distributed to 9 distributors, direct accounts, and relabelers, who may have further distributed the product throughout the United States.
Consumers should check their inventory for the specific lot numbers and expiration dates listed in the recall notice. If you possess the affected product, you should stop using it and contact the manufacturer or your healthcare provider for instructions on disposal or replacement.
The recalled product
- Product
- Robafen DM Syrup (Dextromethorphan HBr, USP 20 mg/10 mL and Guaifenesin, USP 200 mg/10 mL), a) 4 oz. bottle, NDC: 0904-0053-00, b) 8 oz. bottle, NDC: 0904-0053-09, c) 16 oz. bottle, NDC:0904-0053-16, Distributed by Major Pharmaceuticals Inc., Livonia MI 48152.
- Manufacturer
- Torrent Pharma Inc
- Category
- Drug — Cough and Cold
- Hazard
- Affected units
- 1,500,672
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot #s: a) 17F001
- Exp. 06/2019
- 17G016
- Exp. 07/2019
- 17H017
- Exp. 08/2019
- 17L002
- 17L024
- Exp. 11/2019
- 17M010
- 17M013
- Exp. 12/2019
- 18B006
- 18B031
- Exp. 02/2020
- 18C033
- Exp. 03/2020
- 18D015
- 18D016
- Exp. 04/2020
Distribution
Distribution scope not specified by the agency.
Part of a larger recall action
This product is one of 41 recalled by Torrent Pharma Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 41 products in this recall →Related recalls
Same manufacturer · Torrent Pharma Inc
See all →- HighFluoxetine Tablets USP 20 mg Recalled for N-Nitroso Contamination
FDA (Drugs) · 2025-06-11
- SevereFluoxetine Tablets 20 mg Recalled for N-Nitroso Impurity
FDA (Drugs) · 2025-06-11
- High
- ModerateCarbamazepine tablets recalled for failed dissolution specifications
FDA (Drugs) · 2022-01-19
- ModerateTelmisartan and Hydrochlorothiazide Tablets Recalled for Superpotency
FDA (Drugs) · 2021-12-22
Same hazard · bacterial contamination
See all →- HighClorox Recalls Scented Mistolin and Lestoil Cleaners in Puerto Rico
CPSC · 2026-09-03
- HighCurry chicken salad flagged for possible Listeria contamination in two states
USDA FSIS · 2026-07-30
- ModerateMedline Medical Convenience Kits Recalled Due to Potential Bacillus Contamination
FDA (Devices) · 2026-07-29
- HighMedline Convenience Kits Recalled Over Bacillus Contamination
FDA (Devices) · 2026-07-29
- SevereSurgical Convenience Kit Recalled for Bacterial Contaminant in Alcohol Prep Pads
FDA (Devices) · 2026-07-08